+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

The Worldwide Market for Point-of-Care (POC) Testing (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, Pregnancy Testing, Glucose Testing and Other POC)

  • ID: 4764927
  • Report
  • Region: Global
  • 623 Pages
  • Kalorama Information
1 of 4

FEATURED COMPANIES

  • Abaxis, Inc.
  • Beckman Coulter, Inc
  • Clarity Diagnostics, LLC
  • GenBio
  • Medix Biochemica
  • Quidel Corporation
  • MORE

Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years as demand for accurate and fast testing has grown both inside and outside the hospital setting. The increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and, most recently, convenience clinics. This Worldwide Market for Point-of-Care (POC) Diagnostics takes a deep look at the POC diagnostic industry, part of a paradigm shift from curative medicine to predictive, personalized and preemptive medicine.

Global Market Analysis

The global POC testing market is composed of two major categories: professional testing, which includes physician office labs, clinic labs, employer labs and hospital labs, and self-testing, which includes home, drug store testing and continuous glucose testing. The report presents market analysis by product categories, market analysis by subcategory, market analysis by device technology, market analysis by country (including the United States, Europe, Japan, and rest of world), and competitive analysis.

The following global market data are provided:

  • Global POC Test Market, 2016-2023 (in millions $ at manufacturer level)
  • Global POC Testing Market Analysis by Product Category, 2018 (in millions $) (Self-Testing, Professional Testing, Total)
  • Global POC Self-Testing Market Analysis by Product Category, 2018 (in millions$) (Glucose [includes CGM], Pregnancy & Fertility, Fecal Occult Blood, Rapid Coagulation, Drugs of Abuse, Urine, Infectious Disease, Lipid, Total)
  • Global POC Professional Testing Market Analysis by Product Subcategory, 2018 (in millions$) (Drugs of Abuse, Glucose includes HbA1c, Blood & Electrolytes, Infectious Disease, Rapid Coagulation, Fecal Occult Blood, Cardiac Markers, Lipid, Pregnancy & Fertility, Miscellaneous, Urine, Cancer Tumor Markers, Total)
  • POC Testing by End-user, 2018 (%) (Hospitals, Others)
  • Global POC Market by Technology by Sales, 2018 (%) (LFA, Biosensors, Analyzers, Strips)
  • US POC Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Europe POC Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Global POC Testing Market Analysis by European Region, 2018 (in millions $) (W. Europe, E. Europe, Total)
  • Japan POC Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Global POC Testing Market Analysis by Rest of World Region/Country, 2018 (in millions $) (Latin America and Mexico, China, Australia, South Korea, India, Other, Total)
  • Global POC Testing Analysis by Region/Country, 2018 (in millions $) (United States, Europe, Japan, ROW, Total)

Segment Size and Growth

POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use. At the same time more, decentralized test venues invest in non-waived rapid tests and instruments. POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care. New technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record. As the menu for point-of-care testing continues to expand, the report looks in-depth at the following market segments:

  • Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Global POC Diabetes Sales by Test Category, 2018-2023 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; $ millions)
  • Global POC Glucose Self-Testing Market (excludes continuous glucose devices) 2018-2023 (in millions $ at manufacturer level)
  • Global POC Continuous Glucose Self-Testing Market 2018-2023 (in millions $ at manufacturer level)
  • Global POC Glucose Professional Testing Market (excludes HbA1c testing) 2018-2023 (in millions $ at manufacturer level)
  • Global POC Glucose HbA1c Professional Testing Market 2018-2023 (in millions $ at manufacturer level)
  • Global POC Blood and Electrolytes Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Global POC Blood & Electrolytes Sales by Test Category, 2018-2023 ($ millions) (Blood Gases & Electrolytes [inc critical care], Hematocrit/Hemoglobin, WBC other routine)
  • Global Rapid Coagulation Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Total Rapid Cardiac Markers Tests Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Global POC Drugs of Abuse Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Global POC Drugs of Abuse Self Testing Market, 2018-2023 (includes continuous glucose devices)
  • Global POC Drugs of Abuse Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Global POC Pregnancy and Fertility Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • POC Pregnancy and Fertility Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • POC Pregnancy and Fertility Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2016-2023 (in millions of dollars at the manufacturer’s level)
  • POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Global POC Infectious Disease Testing Market Analysis: 2016-2023 (in millions of dollars at the manufacturer’s level)
  • POC Infectious Disease Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • POC Infectious Disease Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type, 2018 (in millions $) (Influenza, HIV, STD, Hepatitis, Malaria, C. difficile, E. coli, H. pylori, Home Test/OTC, Others, Total)
  • Global POC Lipid Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • POC Lipid Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • POC Lipid Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Global POC Cancer Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Global POC Urine Testing Market Analysis, 2016-2028 (in millions of dollars at the manufacturer’s level)
  • POC Urine Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • POC Urine Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Global Miscellaneous POC Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)

Regional Analysis

Selected POC segments represent higher growth prospects for vendors and manufacturers due to clinical drivers in established POC markets (United States, Europe) and developing markets alike. Promising developments in emerging regions include the introduction and success of Western-style physician practices and multi-specialty clinics that perform many standard POC rapid tests. Worldwide Market for Point-of-Care (POC) Diagnostics provides information for specific geographical regions, including:

  • POC Blood Glucose Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Blood and Electrolytes Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Rapid Coagulation Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Rapid Coagulation Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • POC Rapid Coagulation Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • POC Rapid Cardiac Markers Testing Regional Market Analysis, 2018 (US; Europe; Japan; Latin A, AP, India; RoW)
  • POC Substance Abuse Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Pregnancy and Fertility Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Colon Cancer Screening/FOB Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Infectious Disease Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Lipid Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Cancer Tumor Marker Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Urine Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Miscellaneous Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)

Competitive Analysis

The POC market is considered evolving with growth opportunity. The report provides revenues and market share of leading suppliers across market segments, including:

  • Global POC Blood Glucose Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions$)
  • Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2018
  • Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Global POC Infectious Disease Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)

Developing and developed markets alike have room to grow due to an aging population worldwide, drawing companies both large and small into the development and/or marketing of POC tests. Among the innovative competitors discussed within the report’s corporate profiles are:

  • 1 Step Detect Associates, LLC
  • Abaxis, Inc.
  • Abbott Laboratories
  • Abingdon Health, Ltd.
  • AccessBio, Inc.
  • AccuBioTech Co, Ltd.
  • Accutech, LLC
  • ACON Laboratories, Inc
  • Aerscher Diagnostics, LLC
  • Akers Biosciences, Inc.
  • Alfa Scientific Designs, Inc
  • American Bio Medica Corporation
  • AmniSure International
  • Aquila Diagnostic Systems, Inc
  • Arkray, Inc.
  • Arlington Scientific, Inc.
  • Artron Laboratories, Inc
  • Ascensia Diabetes Care Holdings AG
  • Ativa Medical Corporation
  • Atlas Genetics Ltd. (Binx Health)
  • Atlas Link Biotech Co., Ltd
  • Audit Diagnostics
  • Augurix Diagnostic
  • Autobio Diagnostics Co., Ltd
  • Axxin
  • Beckman Coulter, Inc
  • Becton Dickinson (BD)
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Bhat Bio-Tech India Private Ltd. (BBI)
  • bioLytical Laboratories
  • BioMedomics, Inc
  • Biomeme, Inc
  • Biomerica, Inc.
  • bioMerieux SA
  • Biophor Diagnostics, Inc
  • Bio-Rad Laboratories Inc.
  • Bioscan Screening Systems, Inc.
  • Biotron Diagnostics, Inc.
  • Biosensia Ltd.
  • BNTX Inc.
  • Boditech Med Inc
  • Boson Biotech Co. Ltd
  • Calypte Biomedical Corporation
  • CARE Products, Inc.
  • Cepheid, Inc
  • Chembio Diagnostic Systems, Inc.
  • Church & Dwight Co. Inc
  • Clarity Diagnostics, LLC
  • Confirm Biosciences
  • CTK Biotech, Inc.
  • Daktari Diagnostics
  • Danaher Corporation
  • Dexcom, Inc
  • DIALAB GmbH
  • DiaSys Diagnostic Systems GmbH
  • Diaxonhit (Eurobio scientific)
  • Diazyme Laboratories, Inc.
  • DNA Electronics Ltd. (DNAe)
  • Dragerwerk AG & Co. KGaA
  • Dr. Fooke-Achterrath Laboratorien GmbH
  • DRG International, Inc.
  • Eiken Chemical Co Ltd.
  • EKF Diagnostics Holdings plc
  • ELITechGroup, Inc.
  • Enterix, Inc. (Clinical Genomics)
  • Entopsis
  • Eurolyser Diagnostica GmbH
  • Exact Sciences
  • Exalenz Bioscience Ltd.
  • EY Laboratories
  • FABPulous B.V.
  • Fio Corporation
  • First Check Diagnostics LLC
  • GenBio
  • Genedrive plc
  • GeTein BioMedical, Inc.
  • GlysBy snc
  • Helena Laboratories
  • Hema Diagnostic Systems, LLC (NuGenerex Diagnostics)
  • Hemosure, Inc.
  • HORIBA, Ltd.
  • Immunosciences Lab, Inc.
  • Immunostics, Inc
  • InSilixa, Inc
  • Instrumentation Laboratory
  • JAL Innovation PTE LTD
  • Jant Pharmacal Corporation
  • J. Mitra & Co Pvt. Ltd
  • LamdaGen Corporation
  • LifeScan, Inc
  • LifeSign, LLC
  • Loop Medical
  • Macherey-Nagel GmbH & Co. KG
  • Magnasense Technologies
  • Mbio Diagnostics, Inc
  • Medix Biochemica
  • MedMira, Inc
  • Medtronic, Inc.
  • Menarini Diagnostics srl.
  • Meridian Bioscience, Inc
  • Micronics, Inc
  • Nano-Ditech Corporation
  • Noble Medical, Inc
  • Nova Biomedical, Corp.
  • Oasis Diagnostics Corporation
  • Operon
  • OPKO Health, Inc
  • OPTI Medical Systems, Inc
  • OraSure Technologies, Inc.
  • Polymedco, Inc
  • Polymed Therapeutics Inc.
  • Polymer Technologies, Inc (PTS Diagnostics)
  • Preventis GmbH
  • Princeton Biomeditech Corporation
  • QuantuMDx Group Limited
  • Quidel Corporation
  • Radiometer Medical A/S
  • RENESA UG
  • Response Biomedical Corp
  • Reszon Diagnostics International Sdn. Bhd.
  • Rheonix, Inc
  • Roche Diagnostic Corporation
  • Samsung Healthcare
  • Savyon Diagnostics
  • Sekisui Diagnostics LLC
  • Siemens Healthineers GmbH
  • Siloam Biosciences, Inc
  • Spectral Medical, Inc
  • Sysmex Corporation
  • TECHLAB, Inc.
  • Teco Diagnostics
  • Trinity Biotech PLC
  • Trividia Health
  • Tulip Diagnostics Ltd
  • Veredus Laboratories PTE Ltd
  • Vircell
  • WAMA Diagnostica
  • Wave 80 Biosciences
  • Werfen

Market Issues and Trends

An in-depth look at the global POC testing market yields several interesting facts that are explored in this report. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. Worldwide Market for Point-of-Care (POC) Diagnostics explores the main issues and trends affecting this market, influencing its move into the future. These include wearables, patient-centered healthcare, regulatory hurdles, and reimbursement challenges. Factors driving the development of POC tests are discussed as well, including patient-focused drivers, medical/healthcare-related drivers, technology drivers, and economic drivers.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abaxis, Inc.
  • Beckman Coulter, Inc
  • Clarity Diagnostics, LLC
  • GenBio
  • Medix Biochemica
  • Quidel Corporation
  • MORE

1: Executive Summary

  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
  • Table 1-1: Global POC Test Market, 2016-2023 (in millions $ at manufacturer level)
  • Trends Affecting the Market
  • Competitive Outlook
  • Market Conclusions
  • Conclusion One
  • Conclusion Two
  • Conclusion Three
  • Conclusion Four
  • Conclusion Five
  • Conclusion Six
  • Conclusion Seven

2: Introduction and Overview

  • Point-of-Care Diagnostics Testing
  • Industry Regulations
  • POC Industry Drivers
  • Patient focused drivers
  • Medical/Healthcare related drivers
  • Technology drivers
  • Economic drivers
  • Other drivers
  • POC Test Types
  • Blood
  • Urine
  • Saliva
  • Hair
  • Optical Technologies
  • Breath
  • Conditions Evaluated by POC Diagnostic Testing
  • Cancer
  • Cardiovascular Disease
  • Diabetes
  • Drug Abuse
  • Central Nervous System Stimulants
  • Prevalence and Number of Illicit Drug Users
  • Table 2-1: Estimated Number and Prevalence of Drug Users by Region and Age (15-64) (Africa, North America, South America, Asia, Europe, Oceania, Global Total)
  • Infectious Disease
  • Osteoporosis
  • Pregnancy and Fertility

3: POC Blood Glucose Tests

  • Types of Blood Glucose Testing
  • Fasting Blood Sugar (FBS)
  • 2-Hour Postprandial Blood Sugar (PPBS)
  • Random Blood Sugar
  • Glucose Tolerance Test
  • Glucose Urine Test
  • Glycated Hemoglobin (HbA1c)
  • Products
  • Blood Glucose Self-Testing
  • Table 3-1: Selected Glucose Self-Test Meter Innovations
  • Table 3-2: Selected Apps and Glucose Management IT
  • Continuous Self-Testing
  • Glycated Hemoglobin Tests
  • Table 3-3: Selected POC HbA1c Devices
  • Professional
  • Market Size and Growth
  • Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Table 3-5: Global POC Diabetes Sales by Test Category, 2018-2023 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; $ millions)
  • Regional Analysis
  • Figure 3-1: POC Blood Glucose Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Glucose Self-Testing
  • Table 3-6: Global POC Glucose Self-Testing Market (excludes continuous glucose devices) 2018-2023 (in millions $ at manufacturer level)
  • Table 3-7: Global POC Continuous Glucose Self-Testing Market 2018-2023 (in millions $ at manufacturer level)
  • POC Glucose Professional Testing
  • Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing) 2018-2023 (in millions $ at manufacturer level)
  • Table 3-9: Global POC Glucose HbA1c Professional Testing Market 2018-2023 (in millions $ at manufacturer level)
  • Competitive Analysis
  • Table 3-10: Global POC Blood Glucose Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 3-2: Global POC Glucose Test Manufacturers by Percent, 2018

4: POC Blood and Electrolytes Testing Market

  • Types of Blood and Electrolytes Tests
  • Hemoglobin/Hematocrit
  • WBC
  • Blood Gases
  • Electrolytes
  • Products
  • Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2018
  • Table 4-2: Selected POC Hematology Analyzer Systems, 2018
  • Recent Developments
  • Market Size and Growth
  • Table 4-3: Global POC Blood and Electrolytes Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Table 4-4: Global POC Blood & Electrolytes Sales by Test Category, 2018-2023 ($ millions) (Blood Gases & Electrolytes [inc critical care], Hematocrit/Hemoglobin, WBC other routine)
  • Regional Analysis
  • Figure 4-1: POC Blood and Electrolytes Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Blood and Electrolyte Self-Testing
  • POC Blood and Electrolyte Professional Testing
  • Table 4-5: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Competitive Analysis
  • Table 4-6: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 4-2: Global POC Blood and Electrolyte Testing Market Manufacturers by Percent, 2018

5: POC Rapid Coagulation

  • Products
  • Table 5-1: Selected POC Coagulation Innovations
  • Platelet Testing
  • Table 5-2: Selected Platelet Activity Test Innovations
  • Market Size and Growth
  • Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 5-1: POC Rapid Coagulation Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Rapid Coagulation Self-Testing
  • Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • POC Rapid Coagulation Professional Testing
  • Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Competitive Analysis
  • Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions$)
  • Figure 5-2: Global POC Rapid Coagulation Testing Market, Market Share % of Leading Suppliers, 2018

6: POC Rapid Cardiac Markers

  • Products
  • Market Size and Growth
  • Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 6-1: POC Rapid Cardiac Markers Testing Regional Market Analysis, 2018 (US; Europe; Japan; Latin A, AP, India; RoW)
  • Competitive Analysis
  • Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 6-2: Global POC Cardiac Test Manufacturers by Percent, 2018

7: POC Substance Abuse

  • Products
  • Urine
  • Oral
  • Blood
  • Hair
  • Market Size and Growth
  • Table 7-1: Global POC Drugs of Abuse Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 7-1: POC Substance Abuse Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Drugs of Abuse Self-Testing
  • Table 7-2: Global POC Drugs of Abuse Self Testing Market, 2018-2023 (includes continuous glucose devices)
  • POC Drugs of Abuse Professional Testing
  • Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Competitive Analysis
  • Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2018
  • Figure 7-2: Global POC Drug of Abuse Testing Manufacturers by Percent, 2018

8: POC Pregnancy and Fertility Testing

  • Products
  • Table 8-1: Selected Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer’s Instrument / Device / Assay
  • Market Size and Growth
  • Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 8-1: POC Pregnancy and Fertility Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Pregnancy and Fertility Self-Testing
  • Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • POC Pregnancy and Fertility Professional Testing
  • Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Competitive Analysis
  • Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 8-2 Global POC Pregnancy and Fertility Testing Manufacturers by Percent, 2018

9: POC Colon Cancer Screening/Fecal Occult Blood Testing

  • Products
  • Table 9-1: Selected POC Colon Cancer Tests
  • Market Size and Growth
  • Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 9-1: POC Colon Cancer Screening/FOB Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
  • Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing
  • Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Competitive Analysis
  • Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers by Percent, 2018

10: POC Infectious Disease Testing

  • Products
  • HIV and Hepatitis
  • Respiratory
  • STD
  • Tropical Diseases
  • Lyme Disease
  • TB
  • Table 10-1: Innovations in Molecular POC Infectious Disease Diagnostics
  • Market Size and Growth
  • Table 10-2: Global POC Infectious Disease Testing Market Analysis: 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 10-1: POC Infectious Disease Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Infectious Disease Self-Testing
  • Table 10-3: POC Infectious Disease Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • POC Infectious Disease Professional Testing
  • Table 10-4: POC Infectious Disease Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • POC Infectious Disease Testing by Disease Type
  • Table 10-5: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type, 2018 (in millions $) (Influenza, HIV, STD, Hepatitis, Malaria, C. difficile, E. coli, H. pylori, Home Test/OTC, Others, Total)
  • Competitive Analysis
  • Table 10-6: Global POC Infectious Disease Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 10-2: Global POC Infectious Disease Test Manufacturers by Percent, 2018

11: POC Lipid Testing

  • Products
  • Market Size and Growth
  • Table 11-1: Global POC Lipid Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 11-1: POC Lipid Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Lipid Self-Testing
  • Table 11-2: POC Lipid Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • POC Lipid Professional Testing
  • Table 11-3: POC Lipid Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Competitive Analysis
  • Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 11-2: Global POC Lipid Testing Manufacturers by Percent, 2018

12: POC Cancer Tumor Marker Testing

  • Products
  • Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
  • Market Size and Growth
  • Table 12-2: Global POC Cancer Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 12-1: POC Cancer Tumor Marker Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • Competitive Analysis
  • Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 12-2: Global POC Cancer Testing Manufacturers by Percent, 2018

13: POC Urine Testing

  • Products
  • Market Size and Growth
  • Table 13-1: Global POC Urine Testing Market Analysis, 2016-2028 (in millions of dollars at the manufacturer’s level)
  • Regional Analysis
  • Figure 13-1: POC Urine Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
  • POC Urine Self-Testing
  • Table 13-2: POC Urine Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • POC Urine Test Professional Testing
  • Table 13-3: POC Urine Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Competitive Analysis
  • Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 13-2: Global POC Urine Strip Testing Manufacturers by Percent, 2018

14: Miscellaneous POC Testing

  • Microbiology
  • TSH
  • Allergy
  • Autoimmune
  • Others
  • Market Size and Growth
  • Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Table 14-2: Global POC Miscellaneous Sales by Test Category, 2018-2023 (Microbiology, TSH, Allergy, Autoimmune, Others, Total; $ millions)
  • Regional Analysis
  • Figure 14-1: POC Miscellaneous Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)

15: Issues and Trends

  • Overview
  • Wearables
  • Table 15-1: Selected Wearable Devices
  • Patient-centered Healthcare
  • Breath Test Advances
  • Table 15-2: Selected Disease Markers in Exhaled Breath
  • Regulatory Hurdles
  • Reimbursement Challenges
  • Competition
  • POC and Molecular Diagnostics
  • Table 15-3: Selected Market Available Molecular POC Diagnostic Platforms
  • POC and Biosensors and Microfluidics
  • Table 15-4: Selected FDA-Approved Microfluidic-based POC Tests 2018
  • Table 15-5: Selected Biochip and Biosensor Players, 2018
  • Emerging POC Technologies
  • POC Connectivity
  • Multiplexed POC Testing
  • Figure 15-1: Multiplexed POC Testing Schematic
  • The Emergence of Non-invasive Technologies
  • Saliva and Swab
  • Optical Techniques

16: Total Global POC Testing Market and Competitor Analysis

  • Market Overview
  • Table 16-1: Global POC Test Market, 2016-2023 (in millions $ at manufacturer level)
  • Market Analysis by Product Categories
  • Table 16-2: Global POC Testing Market Analysis by Product Category, 2018 (in millions $) (Self-Testing, Professional Testing, Total)
  • Market Analysis by Subcategory
  • POC Self-Testing
  • Table 16-3: Global POC Self-Testing Market Analysis by Product Category, 2018 (in millions$) (Glucose [includes CGM], Pregnancy & Fertility, Fecal Occult Blood, Rapid Coagulation, Drugs of Abuse, Urine, Infectious Disease, Lipid, Total)
  • Figure 16-1: Global POC Self-Testing Market Analysis by Product Category, 2018 (by %) (Infectious Disease, Urine, Drugs of Abuse [DOA], Coagulation, Fecal Occult Blood [FOB], Pregnancy, Glucose)
  • POC Professional Testing
  • Table 16-4: Global POC Professional Testing Market Analysis by Product Subcategory, 2018 (in millions$) (Drugs of Abuse, Glucose includes HbA1c, Blood & Electrolytes, Infectious Disease, Rapid Coagulation, Fecal Occult Blood, Cardiac Markers, Lipid, Pregnancy & Fertility, Miscellaneous, Urine, Cancer Tumor Markers, Total)
  • Figure 16-2: Global POC Professional Testing Market Analysis by Product Subcategory, 2018 (by %) (Tumor Markers, Urine, Miscellaneous, Pregnancy, Lipid, Cardiac Markers, FOB, Coagulation, Infectious Disease, Blood/Electrolytes, Glucose/HbA1c, DOA)
  • POC Testing by End-Use
  • Figure 16-3: POC Testing by End-user, 2018 (%) (Hospitals, Others)
  • Market by Device Technology
  • Figure 16-4: Global POC Market by Technology by Sales, 2018 (%) (LFA, Biosensors, Analyzers, Strips)
  • Market Analysis by Country
  • United States
  • Table 16-5: US POC Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Europe
  • Table 16-6: Europe POC Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Table 16-7: Global POC Testing Market Analysis by European Region, 2018 (in millions $) (W. Europe, E. Europe, Total)
  • Figure 16-5: EU POC Testing Percentage Participation, by Country, 2018 (%) (Germany, UK, France, Italy, Switzerland/Sweden, Spain, Other)
  • Japan
  • Table 16-8: Japan POC Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Rest of World
  • Table 16-9: Global POC Testing Market Analysis by Rest of World Region/Country, 2018 (in millions $) (Latin America and Mexico, China, Australia, South Korea, India, Other, Total)
  • Figure 16-6: Global POC Testing Market Analysis by Rest of World Region/Country, 2018 (%) (Latin America/Mexico, China, Australia, South Korea, India, Others)
  • Table 16-10: Global POC Testing Analysis by Region/Country, 2018 (in millions $) (United States, Europe, Japan, ROW, Total)
  • Figure 16-7: Global POC Testing Market Analysis Percent by Region/Country, 2018 (US, Europe, Japan, RoW)
  • Competitive Analysis
  • Table 16-11: Global POC Testing Market Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 16-8: Global POC Testing Market Share by Leading Suppliers, 2018

17: Corporate Profiles

  • Overview
  • 1 Step Detect Associates, LLC
  • Table 17-1: 1-Step Detect Associates Corporate Summary
  • Company Overview
  • Products
  • Abaxis, Inc.
  • Table 17-2: Abaxis Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-3: Abaxis Revenues 2016-2018 (in thousands $)
  • Abbott Laboratories
  • Table 17-4: Abbott Corporate Summary
  • Company Overview
  • Alere Acquisition Update
  • Products
  • Performance Review
  • Table 17-5: Abbott Revenues 2016-2018 (in millions $)
  • Abingdon Health, Ltd.
  • Table 17-6: Abingdon Health Corporate Summary
  • Company Overview
  • Products
  • AccessBio, Inc.
  • Table 17-7: AccessBio Corporate Summary
  • Company Overview
  • Products
  • AccuBioTech Co, Ltd.
  • Table 17-8: AccuBioTech Corporate Summary
  • Company Overview
  • Products
  • Accutech, LLC
  • Table 17-9: Accutech Corporate Summary
  • Company Overview
  • Products
  • ACON Laboratories, Inc
  • Table 17-10: ACON Laboratories Corporate Summary
  • Company Overview
  • Products
  • Aerscher Diagnostics, LLC
  • Table 17-11: Aerscher Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Akers Biosciences, Inc.
  • Table 17-12: Akers Biosciences Corporate Summary
  • Company Overview
  • Products
  • Company Financials
  • Table 17-13: Akers Corporation Revenue (2015-2018) ($ thousands)
  • Alfa Scientific Designs, Inc
  • Table 17-14: Alfa Scientific Corporate Summary
  • Company Overview
  • Products
  • American Bio Medica Corporation
  • Table 17-15: American Bio Medica Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-16: American Bio Medica Corporation Revenue (2015-2018) ($ millions)
  • AmniSure International
  • Table 17-17: AmniSure International Corporate Summary
  • Company Overview
  • Products
  • Aquila Diagnostic Systems, Inc
  • Table 17-18: Aquila Diagnostic Systems Summary
  • Company Overview
  • Products
  • Arkray, Inc.
  • Table 17-19: Arkray Corporate Summary
  • Company Overview
  • Products
  • Arlington Scientific, Inc.
  • Table 17-20: Arlington Scientific Corporate Summary
  • Company Overview
  • Products
  • Artron Laboratories, Inc
  • Table 17-21: Artron Laboratories Corporate Summary
  • Company Overview
  • Products
  • Ascensia Diabetes Care Holdings AG
  • Table 17-22: Ascensia Diabetes Care Corporate Summary
  • Company Overview
  • Products
  • Ativa Medical Corporation
  • Table 17-23: Ativa Medical Corporate Summary
  • Company Overview
  • Products
  • Atlas Genetics Ltd. (Binx Health)
  • Table 17-24: Atlas Genetics Corporate Summary
  • Company Overview
  • Products
  • Atlas Link Biotech Co., Ltd
  • Table 17-25: Atlas Link Biotech Corporate Summary
  • Company Overview
  • Products
  • Audit Diagnostics
  • Table 17-26: Audit Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Augurix Diagnostic
  • Table 17-27: Augurix Diagnostic Corporate Summary
  • Company Overview
  • Products
  • Autobio Diagnostics Co., Ltd
  • Table 17-28: Autobio Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Axxin
  • Table 17-29: Axxin Corporate Summary
  • Company Overview
  • Products
  • Beckman Coulter, Inc
  • Table 17-30: Beckman Coulter Corporate Summary
  • Company Overview
  • Products
  • Company Financials
  • Table 17-31: Beckman Coulter Revenue (2015-2018) ($ millions)
  • Becton Dickinson (BD)
  • Table 17-32: BD Corporate Summary
  • Company Overview
  • Products
  • Company Financials
  • Table 17-33: BD Corporation Revenue (2015-2018) ($ millions)
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Table 17-34: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
  • Company Overview
  • Products
  • Bhat Bio-Tech India Private Ltd. (BBI)
  • Table 17-35: Bhat Bio-Tech India Private Corporate Summary
  • Company Overview
  • Products
  • bioLytical Laboratories
  • Table 17-36: bioLytical Laboratories Corporate Summary
  • Company Overview
  • Products
  • BioMedomics, Inc
  • Table 17-37: BioMedomics Corporate Summary
  • Company Overview
  • Products
  • Biomeme, Inc
  • Table 17-38: Biomeme Corporate Summary
  • Company Overview
  • Products
  • Biomerica, Inc.
  • Table 17-39: Biomerica Corporate Summary
  • Company Overview
  • Products
  • Company Financials
  • Table 17-40: Biomerica Corporation Revenue (2015-2018) ($ millions)
  • bioMerieux SA
  • Table 17-41: bioMerieux SA Corporate Summary
  • Company Overview
  • Products
  • Company Financials
  • Table 17-42: bioMerieux Revenues (2015-2018) ($ millions)
  • Biophor Diagnostics, Inc
  • Table 17-43: Biophor Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Bio-Rad Laboratories Inc.
  • Table 17-44: Bio-Rad Labs Corporate Summary
  • Company Overview
  • Products
  • Company Financials
  • Table 17-45: Bio-Rad Corporation Revenue (2015-2018) ($ millions)
  • Bioscan Screening Systems, Inc.
  • Table 17-46: Bioscan Screening Systems Corporate Summary
  • Company Overview
  • Products
  • Biotron Diagnostics, Inc.
  • Table 17-47: Biotron Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Biosensia Ltd.
  • Table 17-48: Biosensia Corporate Summary
  • Company Overview
  • Products
  • BNTX Inc.
  • Table 17-49: BNTX Corporate Summary
  • Company Overview
  • Products
  • Boditech Med Inc
  • Table 17-50: Boditech Med Corporate Summary
  • Company Overview
  • Products
  • Boson Biotech Co. Ltd
  • Table 17-51: Boson Biotech Corporate Summary
  • Company Overview
  • Products
  • Calypte Biomedical Corporation
  • Table 17-52: Calypte Biomedical Corporate Summary
  • Company Overview
  • Products
  • CARE Products, Inc.
  • Table 17-53: CARE Products Corporate Summary
  • Company Overview
  • Products
  • Cepheid, Inc
  • Table 17-54: Cepheid Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-55: Cepheid Revenues (2015-2018) ($ millions)
  • Chembio Diagnostic Systems, Inc.
  • Table 17-56: Chembio Diagnostic Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-57: Chembio Diagnostics Revenues (2015-2018) ($ millions)
  • Church & Dwight Co. Inc
  • Table 17-58: Church & Dwight Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-59: Church & Dwight Revenues (2015-2018) ($ millions)
  • Clarity Diagnostics, LLC
  • Table 17-60: Clarity Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Confirm Biosciences
  • Table 17-61: Confirm Biosciences Corporate Summary
  • Company Overview
  • Products
  • CTK Biotech, Inc.
  • Table 17-62: CTK Biotech Corporate Summary
  • Company Overview
  • Products
  • Daktari Diagnostics
  • Table 17-63: Daktari Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Danaher Corporation
  • Table 17-64: Danaher Corporation Summary
  • Company Overview
  • Products
  • Company Financials
  • Table 17-65: Danaher Revenues (2015-2018) ($ millions)
  • Dexcom, Inc
  • Table 17-66: Dexcom Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-67: Dexcom Revenues (2015-2018) ($ millions)
  • DIALAB GmbH
  • Table 17-68: DIALAB Corporate Summary
  • Company Overview
  • Products
  • DiaSys Diagnostic Systems GmbH
  • Table 17-69: DiaSys Diagnostic Systems Corporate Summary
  • Company Overview
  • Products
  • Diaxonhit (Eurobio scientific)
  • Table 17-70: Diaxonhit Corporate Summary
  • Company Overview
  • Products
  • Diazyme Laboratories, Inc.
  • Table 17-71: Diazyme Laboratories Corporate Summary
  • Company Overview
  • Products
  • DNA Electronics Ltd. (DNAe)
  • Table 17-72: DNA Electronics Corporate Summary
  • Company Overview
  • Products
  • Dragerwerk AG & Co. KGaA
  • Table 17-73: Dragerwerk Corporate Summary
  • Company Overview
  • Products
  • Company Financials
  • Table 17-74: Dragerwerk Revenues (2015-2018) ($ millions)
  • Fooke-Achterrath Laboratorien GmbH
  • Table 17-75: Fooke-Achterrath Laboratorien Corporate Summary
  • Company Overview
  • Products
  • DRG International, Inc.
  • Table 17-76: DRG International Corporate Summary
  • Company Overview
  • Products
  • Eiken Chemical Co Ltd.
  • Table 17-77: Eiken Chemical Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-78: Eiken Chemical Revenues (2015-2018) ($ millions)
  • EKF Diagnostics Holdings plc
  • Table 17-79: EKF Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-80: EKF Diagnostics Revenues (2015-2018) ($ millions)
  • ELITechGroup, Inc.
  • Table 17-81: ELITechGroup Corporate Summary
  • Company Overview
  • Products
  • Enterix, Inc. (Clinical Genomics)
  • Table 17-82: Enterix Corporate Summary
  • Company Overview
  • Products
  • Entopsis
  • Table 17-83: Entopsis Corporate Summary
  • Company Overview
  • Products
  • Eurolyser Diagnostica GmbH
  • Table 17-84: Eurolyser Diagnostica Corporate Summary
  • Company Overview
  • Products
  • Exact Sciences
  • Table 17-85: Exact Sciences Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-86: Exact Sciences Revenues (2015-2018) ($ millions)
  • Exalenz Bioscience Ltd.
  • Table 17-87: Exalenz Bioscience Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-88: Exalenz Bioscience Revenues (2015-2018) ($ millions)
  • EY Laboratories
  • Table 17-89: EY Laboratories Corporate Summary
  • Company Overview
  • Products
  • FABPulous B.V.
  • Table 17-90: FABPulous Corporate Summary
  • Company Overview
  • Products
  • Fio Corporation
  • Table 17-91: Fio Corporate Summary
  • Company Overview
  • Products
  • First Check Diagnostics LLC
  • Table 17-92: First Check Diagnostics Corporate Summary
  • Company Overview
  • Products
  • GenBio
  • Table 17-93: GenBio Corporate Summary
  • Company Overview
  • Products
  • Genedrive plc
  • Table 17-94: Genedrive Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-95: Genedrive Revenues (2015-2018) ($ millions)
  • GeTein BioMedical, Inc.
  • Table 17-96: GeTein Corporate Summary
  • Company Overview
  • Products
  • GlysBy snc
  • Table 17-97: GlysBy Corporate Summary
  • Company Overview
  • Products
  • Helena Laboratories
  • Table 17-98: Helena Laboratories Corporate Summary
  • Company Overview
  • Products
  • Hema Diagnostic Systems, LLC (NuGenerex Diagnostics)
  • Table 17-99: Hema Diagnostics Systems Corporate Summary
  • Company Overview
  • Products
  • Hemosure, Inc.
  • Table 17-100: Hemosure Corporate Summary
  • Company Overview
  • Products
  • HORIBA, Ltd.
  • Table 17-101: HORIBA Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-102: HORIBA Revenues (2015-2018) ($ millions)
  • Immunosciences Lab, Inc.
  • Table 17-103: Immunosciences Lab Corporate Summary
  • Company Overview
  • Products
  • Immunostics, Inc
  • Table 17-104: Immunostics Corporate Summary
  • Company Overview
  • Products
  • InSilixa, Inc
  • Table 17-105: InSilixa Corporate Summary
  • Company Overview
  • Products
  • Instrumentation Laboratory
  • Table 17-106: Instrumentation Laboratory Corporate Summary
  • Company Overview
  • Products
  • JAL Innovation PTE LTD
  • Table 17-107: JAL Innovation Corporate Summary
  • Company Overview
  • Products
  • Jant Pharmacal Corporation
  • Table 17-108: Jant Pharmacal Corporate Summary
  • Company Overview
  • Products
  • Mitra & Co Pvt. Ltd
  • Table 17-109: J Mitra Corporate Summary
  • Company Overview
  • Products
  • LamdaGen Corporation
  • Table 17-110: LamdaGen Corporate Summary
  • Company Overview
  • Products
  • LifeScan, Inc
  • Table 17-111: LifeScan Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-112: LifeScan Revenues (2015-2018 ($ thousands)
  • LifeSign, LLC
  • Table 17-113: LifeSign Corporate Summary
  • Company Overview
  • Products
  • Loop Medical
  • Table 17-114 Loop Medical Corporate Summary
  • Company Overview
  • Products
  • Macherey-Nagel GmbH & Co. KG
  • Table 17-115: Macherey-Nagel Corporate Summary
  • Company Overview
  • Products
  • Magnasense Technologies
  • Table 17-116: Magnasense Technologies Corporate Summary
  • Company Overview
  • Products
  • Mbio Diagnostics, Inc
  • Table 17-117: Mbio Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Medix Biochemica
  • Table 17-118: Medix Biochemica Corporate Summary
  • Company Overview
  • Products
  • MedMira, Inc
  • Table 17-119: MedMira Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-120: MedMira Revenues (2015-2018) ($ thousands)
  • Medtronic, Inc.
  • Table 17-121: Medtronic Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-122: Medtronic Revenues (2015-2018) ($ millions)
  • Menarini Diagnostics srl.
  • Table 17-123: Menarini Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Meridian Bioscience, Inc
  • Table 17-124: Meridian Bioscience Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-125: Meridian Bioscience (2015-2018) ($ millions)
  • Micronics, Inc
  • Table 17-126: Micronics Corporate Summary
  • Company Overview
  • Products
  • Nano-Ditech Corporation
  • Table 17-127: Nano-Ditech Corporate Summary
  • Company Overview
  • Products
  • Noble Medical, Inc
  • Table 17-128: Noble Medical Corporate Summary
  • Company Overview
  • Products
  • Nova Biomedical, Corp.
  • Table 17-129: Nova Biomedical Corporate Summary
  • Company Overview
  • Products
  • Oasis Diagnostics Corporation
  • Table 17-130: Oasis Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Operon
  • Table 17-131: Operon Corporate Summary
  • Company Overview
  • Products
  • OPKO Health, Inc
  • Table 17-132: OPKO Health Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-133: OPKO Health Revenues (2015-2018) ($ millions)
  • OPTI Medical Systems, Inc
  • Table 17-134: OPTI Medical Corporate Summary
  • Company Overview
  • Products
  • OraSure Technologies, Inc.
  • Table 17-135: OraSure Technologies Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-136: OraSure Revenues (2015-2018) ($ millions)
  • Polymedco, Inc
  • Table 17-137: Polymedco Corporate Summary
  • Company Overview
  • Products
  • Polymed Therapeutics Inc.
  • Table 17-138: Polymed Therapeutics Corporate Summary
  • Company Overview
  • Products
  • Polymer Technologies, Inc (PTS Diagnostics)
  • Table 17-139: Polymer Technologies Corporate Summary
  • Company Overview
  • Products
  • Preventis GmbH
  • Table 17-140: Preventis Corporate Summary
  • Company Overview
  • Products
  • Princeton Biomeditech Corporation
  • Table 17-141: Princeton Biomeditech Corporate Summary
  • Company Overview
  • Products
  • QuantuMDx Group Limited
  • Table 17-142: QuantuMDx Group Corporate Summary
  • Company Overview
  • Products
  • Quidel Corporation
  • Table 17-143: Quidel Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-144: Quidel Revenues (2015-2018) ($ millions)
  • Radiometer Medical A/S
  • Table 17-145: Radiometer Medical Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-146: Radiometer (2015-2018) ($ millions)
  • RENESA UG
  • Table 17-147: RENESA UG Corporate Summary
  • Company Overview
  • Products
  • Response Biomedical Corp
  • Table 17-148: Response Biomedical Corporate Summary
  • Company Overview
  • Products
  • Reszon Diagnostics International Sdn. Bhd.
  • Table 17-149: Reszon Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Rheonix, Inc
  • Table 17-150: Rheonix Corporate Summary
  • Company Overview
  • Products
  • Roche Diagnostic Corporation
  • Table 17-151: Roche Diagnostic Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-152: Roche Diagnostics (2015-2018) ($ millions)
  • Samsung Healthcare
  • Table 17-153: Samsung Healthcare Corporate Summary
  • Company Overview
  • Products
  • Savyon Diagnostics
  • Table 17-154: Savyon Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Sekisui Diagnostics LLC
  • Table 17-155: Sekisui Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Siemens Healthineers GmbH
  • Table 17-156: Siemens Healthineers Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-157: Siemens Healthineers Revenues (2015-2018) ($ millions)
  • Siloam Biosciences, Inc
  • Table 17-158: Siloam Biosciences Summary
  • Company Overview
  • Products
  • Spectral Medical, Inc
  • Table 17-159: Spectral Medical Summary
  • Company Overview
  • Sysmex Corporation
  • Table 17-160 Sysmex Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-161: Sysmex Revenues (2015-2018) ($ millions)
  • TECHLAB, Inc.
  • Table 17-162: TECHLAB Corporate Summary
  • Company Overview
  • Products
  • Teco Diagnostics
  • Table 17-163: Teco Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Trinity Biotech PLC
  • Table 17-164: Trinity Biotech Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-165: Trinity Biotech Revenue (2015-2018) ($ millions)
  • Trividia Health
  • Table 17-166: Trividia Health Corporate Summary
  • Company Overview
  • Products
  • Tulip Diagnostics Ltd
  • Table 17-167: Tulip Diagnostics Corporate Summary
  • Company Overview
  • Product
  • Veredus Laboratories PTE Ltd
  • Table 17-168: Veredus Labs Corporate Summary
  • Company Overview
  • Products
  • Vircell
  • Table 17-169: Vircell Corporate Summary
  • Company Overview
  • Products
  • WAMA Diagnostica
  • Table 17-170: WAMA Diagnostica Corporate Summary
  • Company Overview
  • Products
  • Wave 80 Biosciences
  • Table 17-171: Wave 80 Biosciences Corporate Summary
  • Company Overview
  • Products
  • Werfen
  • Table 17-172: Werfen Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 17-173: Werfen Revenues (2015-2018) ($ millions)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 1 Step Detect Associates, LLC
  • Abaxis, Inc.
  • Abbott Laboratories
  • Abingdon Health, Ltd.
  • AccessBio, Inc.
  • AccuBioTech Co, Ltd.
  • Accutech, LLC
  • ACON Laboratories, Inc
  • Aerscher Diagnostics, LLC
  • Akers Biosciences, Inc.
  • Alere Acquisition Update
  • Alfa Scientific Designs, Inc
  • American Bio Medica Corporation
  • AmniSure International
  • Aquila Diagnostic Systems, Inc
  • Arkray, Inc.
  • Arlington Scientific, Inc.
  • Artron Laboratories, Inc
  • Ascensia Diabetes Care Holdings AG
  • Ativa Medical Corporation
  • Atlas Genetics Ltd. (Binx Health)
  • Atlas Link Biotech Co., Ltd
  • Audit Diagnostics
  • Augurix Diagnostic
  • Autobio Diagnostics Co., Ltd
  • Axxin
  • Beckman Coulter, Inc
  • Becton Dickinson (BD)
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Bhat Bio-Tech India Private Ltd. (BBI)
  • Bio-Rad Laboratories Inc.
  • bioLytical Laboratories
  • BioMedomics, Inc
  • Biomeme, Inc
  • Biomerica, Inc.
  • bioMerieux SA
  • Biophor Diagnostics, Inc
  • Bioscan Screening Systems, Inc.
  • Biosensia Ltd.
  • Biotron Diagnostics, Inc.
  • BNTX Inc.
  • Boditech Med Inc
  • Boson Biotech Co. Ltd
  • Calypte Biomedical Corporation
  • CARE , Inc.
  • Cepheid, Inc
  • Chembio Diagnostic Systems, Inc.
  • Church & Dwight Co. Inc
  • Clarity Diagnostics, LLC
  • Confirm Biosciences
  • CTK Biotech, Inc.
  • Daktari Diagnostics
  • Danaher Corporation
  • Dexcom, Inc
  • DIALAB GmbH
  • DiaSys Diagnostic Systems GmbH
  • Diaxonhit (Eurobio scientific)
  • Diazyme Laboratories, Inc.
  • DNA Electronics Ltd. (DNAe)
  • Dragerwerk AG & Co. KGaA
  • DRG International, Inc.
  • Eiken Chemical Co Ltd.
  • EKF Diagnostics Holdings plc
  • ELITechGroup, Inc.
  • Enterix, Inc. (Clinical Genomics)
  • Entopsis
  • Eurolyser Diagnostica GmbH
  • Exact Sciences
  • Exalenz Bioscience Ltd.
  • EY Laboratories
  • FABPulous B.V.
  • Fio Corporation
  • First Check Diagnostics LLC
  • Fooke-Achterrath Laboratorien GmbH
  • GenBio
  • Genedrive plc
  • GeTein BioMedical, Inc.
  • GlysBy snc
  • Helena Laboratories
  • Hema Diagnostic Systems, LLC (NuGenerex Diagnostics)
  • Hemosure, Inc.
  • HORIBA, Ltd.
  • Immunosciences Lab, Inc.
  • Immunostics, Inc
  • InSilixa, Inc
  • Instrumentation Laboratory
  • JAL Innovation PTE LTD
  • Jant Pharmacal Corporation
  • LamdaGen Corporation
  • LifeScan, Inc
  • LifeSign, LLC
  • Loop Medical
  • Macherey-Nagel GmbH & Co. KG
  • Magnasense Technologies
  • Mbio Diagnostics, Inc
  • Medix Biochemica
  • MedMira, Inc
  • Medtronic, Inc.
  • Menarini Diagnostics srl.
  • Meridian Bioscience, Inc
  • Micronics, Inc
  • Mitra & Co Pvt. Ltd
  • Nano-Ditech Corporation
  • Noble Medical, Inc
  • Nova Biomedical, Corp.
  • Oasis Diagnostics Corporation
  • Operon
  • OPKO Health, Inc
  • OPTI Medical Systems, Inc
  • OraSure Technologies, Inc.
  • Polymed Therapeutics Inc.
  • Polymedco, Inc
  • Polymer Technologies, Inc (PTS Diagnostics)
  • Preventis GmbH
  • Princeton Biomeditech Corporation
  • QuantuMDx Group Limited
  • Quidel Corporation
  • Radiometer Medical A/S
  • RENESA UG
  • Response Biomedical Corp
  • Reszon Diagnostics International Sdn. Bhd.
  • Rheonix, Inc
  • Roche Diagnostic Corporation
  • Samsung Healthcare
  • Savyon Diagnostics
  • Sekisui Diagnostics LLC
  • Siemens Healthineers GmbH
  • Siloam Biosciences, Inc
  • Spectral Medical, Inc
  • Sysmex Corporation
  • TECHLAB, Inc.
  • Teco Diagnostics
  • Trinity Biotech PLC
  • Trividia Health
  • Tulip Diagnostics Ltd
  • Veredus Laboratories PTE Ltd
  • Vircell
  • WAMA Diagnostica
  • Wave 80 Biosciences
  • Werfen
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4764927
Adroll
adroll